Cargando…
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
BACKGROUND: Liver cancer as the main leading cancer has caused heavy burdens globally. The prognosis of liver cancer is closely related with postoperative nutrition support. Corn oligopeptides (COPs) are protein hydrolysates produced by enzymatic treatments, which have shown potential bioactivities,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745621/ https://www.ncbi.nlm.nih.gov/pubmed/36523946 http://dx.doi.org/10.21037/hbsn-21-116 |
_version_ | 1784849188344823808 |
---|---|
author | Rong, Weiqi Xia, Hui Zhang, Kai Zhang, Yihan Tao, Changcheng Wu, Fan Wang, Liming Zhang, Hong Sun, Guiju Wu, Jianxiong |
author_facet | Rong, Weiqi Xia, Hui Zhang, Kai Zhang, Yihan Tao, Changcheng Wu, Fan Wang, Liming Zhang, Hong Sun, Guiju Wu, Jianxiong |
author_sort | Rong, Weiqi |
collection | PubMed |
description | BACKGROUND: Liver cancer as the main leading cancer has caused heavy burdens globally. The prognosis of liver cancer is closely related with postoperative nutrition support. Corn oligopeptides (COPs) are protein hydrolysates produced by enzymatic treatments, which have shown potential bioactivities, such as inhibiting angiotensin I-converting enzyme, resisting lipid peroxidation and anti-oxidant. However, the correlation between COPs and liver cancer patients is still unknown and the potential mechanism of COPs on liver cancer is unclear as well. The aim of this study was to assess effects of 7-day intervention of COPs after surgery on liver function and serum metabolic profiles of liver cancer patients. METHODS: Patients were assigned into COPs intervention group (n=50) and control group (n=91) for 7 days. Investigations were scheduled at 1(st) day and 7(th) day after liver resection surgery respectively, mainly including anthropometric, biochemical indexes and liquid chromatography-mass spectrometry (LC/MS) analysis. RESULTS: Seven-day supplementation of COPs on early post-surgery liver cancer patients down-regulated levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin and up-regulated prothrombin time activity and prealbumin levels. LC/MS analysis revealed metabolic signatures including regulation of 16 metabolites, which was closely related with two metabolic pathways (nicotinate and nicotinamide metabolism, fatty acid metabolism). CONCLUSIONS: COPs supplementation has displayed the potentials on alleviating the injury of liver function and it may be due to regulation of fatty acid metabolism, nicotinate and nicotinamide metabolism, lipid peroxidation and anti-inflammatory action. More researches are warranted in future to confirm the exact mechanisms. |
format | Online Article Text |
id | pubmed-9745621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-97456212022-12-14 Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial Rong, Weiqi Xia, Hui Zhang, Kai Zhang, Yihan Tao, Changcheng Wu, Fan Wang, Liming Zhang, Hong Sun, Guiju Wu, Jianxiong Hepatobiliary Surg Nutr Original Article BACKGROUND: Liver cancer as the main leading cancer has caused heavy burdens globally. The prognosis of liver cancer is closely related with postoperative nutrition support. Corn oligopeptides (COPs) are protein hydrolysates produced by enzymatic treatments, which have shown potential bioactivities, such as inhibiting angiotensin I-converting enzyme, resisting lipid peroxidation and anti-oxidant. However, the correlation between COPs and liver cancer patients is still unknown and the potential mechanism of COPs on liver cancer is unclear as well. The aim of this study was to assess effects of 7-day intervention of COPs after surgery on liver function and serum metabolic profiles of liver cancer patients. METHODS: Patients were assigned into COPs intervention group (n=50) and control group (n=91) for 7 days. Investigations were scheduled at 1(st) day and 7(th) day after liver resection surgery respectively, mainly including anthropometric, biochemical indexes and liquid chromatography-mass spectrometry (LC/MS) analysis. RESULTS: Seven-day supplementation of COPs on early post-surgery liver cancer patients down-regulated levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin and up-regulated prothrombin time activity and prealbumin levels. LC/MS analysis revealed metabolic signatures including regulation of 16 metabolites, which was closely related with two metabolic pathways (nicotinate and nicotinamide metabolism, fatty acid metabolism). CONCLUSIONS: COPs supplementation has displayed the potentials on alleviating the injury of liver function and it may be due to regulation of fatty acid metabolism, nicotinate and nicotinamide metabolism, lipid peroxidation and anti-inflammatory action. More researches are warranted in future to confirm the exact mechanisms. AME Publishing Company 2022-12 /pmc/articles/PMC9745621/ /pubmed/36523946 http://dx.doi.org/10.21037/hbsn-21-116 Text en 2022 Hepatobiliary Surgery and Nutrition. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Rong, Weiqi Xia, Hui Zhang, Kai Zhang, Yihan Tao, Changcheng Wu, Fan Wang, Liming Zhang, Hong Sun, Guiju Wu, Jianxiong Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial |
title | Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial |
title_full | Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial |
title_fullStr | Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial |
title_full_unstemmed | Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial |
title_short | Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial |
title_sort | serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745621/ https://www.ncbi.nlm.nih.gov/pubmed/36523946 http://dx.doi.org/10.21037/hbsn-21-116 |
work_keys_str_mv | AT rongweiqi serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT xiahui serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT zhangkai serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT zhangyihan serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT taochangcheng serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT wufan serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT wangliming serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT zhanghong serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT sunguiju serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial AT wujianxiong serummetaboliceffectsofcornoligopeptideswith7daysupplementationonearlypostsurgeryprimarylivercancerpatientsadoubleblindrandomizedcontrolledtrial |